| No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
| 1 |
chr12:117126000-117131400 |
Weak transcription |
H1 Derived Neuronal Progenitor Cultured Cells |
ES cell derived
|
| 2 |
chr12:117126000-117133000 |
Weak transcription |
Spleen |
Spleen
|
| 3 |
chr12:117126200-117131600 |
Weak transcription |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
| 4 |
chr12:117127600-117134800 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
| 5 |
chr12:117128400-117131000 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
| 6 |
chr12:117129800-117131400 |
Weak transcription |
Gastric |
stomach
|
| 7 |
chr12:117130000-117131200 |
Enhancers |
Fetal Brain Male |
brain
|
| 8 |
chr12:117130200-117131200 |
Bivalent Enhancer |
GM12878-XiMat |
blood
|
| 9 |
chr12:117130200-117131400 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
| 10 |
chr12:117130200-117131600 |
Enhancers |
Primary B cells from cord blood |
blood
|
| 11 |
chr12:117130200-117131600 |
Enhancers |
Fetal Heart |
heart
|
| 12 |
chr12:117130400-117131400 |
Bivalent Enhancer |
Fetal Intestine Large |
intestine
|
| 13 |
chr12:117130400-117132200 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
| 14 |
chr12:117130600-117131000 |
Bivalent Enhancer |
Ganglion Eminence derived primary cultured neurospheres |
brain
|
| 15 |
chr12:117130600-117131000 |
Flanking Active TSS |
Duodenum Mucosa |
Duodenum
|
| 16 |
chr12:117130600-117131200 |
Bivalent Enhancer |
iPS-15b Cell Line |
embryonic stem cell
|
| 17 |
chr12:117130600-117131200 |
Bivalent Enhancer |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
| 18 |
chr12:117130600-117131200 |
Enhancers |
Primary hematopoietic stem cells |
blood
|
| 19 |
chr12:117130600-117131200 |
Enhancers |
Brain Angular Gyrus |
brain
|
| 20 |
chr12:117130600-117131200 |
Bivalent Enhancer |
HepG2 |
liver
|
| 21 |
chr12:117130600-117131400 |
Flanking Active TSS |
Primary monocytes fromperipheralblood |
blood
|
| 22 |
chr12:117130600-117131600 |
Bivalent/Poised TSS |
Osteobl |
bone
|
| 23 |
chr12:117130600-117131800 |
Flanking Active TSS |
Liver |
Liver
|
| 24 |
chr12:117130600-117131800 |
Flanking Active TSS |
Monocytes-CD14+_RO01746 |
blood
|
| 25 |
chr12:117130600-117132400 |
Flanking Active TSS |
Brain Germinal Matrix |
brain
|
| 26 |
chr12:117130800-117131000 |
Bivalent Enhancer |
Primary neutrophils fromperipheralblood |
blood
|
| 27 |
chr12:117130800-117131000 |
Bivalent Enhancer |
Cortex derived primary cultured neurospheres |
brain
|
| 28 |
chr12:117130800-117131000 |
Flanking Active TSS |
Brain Anterior Caudate |
brain
|
| 29 |
chr12:117130800-117131000 |
Enhancers |
Fetal Brain Female |
brain
|
| 30 |
chr12:117130800-117131000 |
Enhancers |
Sigmoid Colon |
Sigmoid Colon
|
| 31 |
chr12:117130800-117131200 |
Bivalent Enhancer |
H9 Derived Neuron Cultured Cells |
ES cell derived
|
| 32 |
chr12:117130800-117131200 |
Enhancers |
HUES48 Cell Line |
embryonic stem cell
|
| 33 |
chr12:117130800-117131200 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
| 34 |
chr12:117130800-117131200 |
Enhancers |
ES-UCSF4 Cell Line |
embryonic stem cell
|
| 35 |
chr12:117130800-117131200 |
Bivalent Enhancer |
Adipose Nuclei |
Adipose
|
| 36 |
chr12:117130800-117131200 |
Enhancers |
Brain Hippocampus Middle |
brain
|
| 37 |
chr12:117130800-117131200 |
Bivalent Enhancer |
Brain Inferior Temporal Lobe |
brain
|
| 38 |
chr12:117130800-117131200 |
Enhancers |
Fetal Lung |
lung
|
| 39 |
chr12:117130800-117131200 |
Enhancers |
Right Atrium |
heart
|
| 40 |
chr12:117130800-117131200 |
Bivalent Enhancer |
Skeletal Muscle Female |
skeletal muscle
|
| 41 |
chr12:117130800-117131400 |
Enhancers |
Fetal Intestine Small |
intestine
|
| 42 |
chr12:117130800-117131800 |
Flanking Active TSS |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|